(Q36703044)

15 August 2017

Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study (English)

1 reference

15 August 2017

1 reference

8

Boris Birmaher

1 reference

15 August 2017

6

Benedetto Vitiello

1 reference

15 August 2017

9

Joan Rosenbaum Asarnow

1 reference

15 August 2017

5

Karen Dineen Wagner

1 reference

15 August 2017

3

Graham J Emslie

1 reference

15 August 2017

Dara J Sakolsky

1

1 reference

15 August 2017

James M Perel

2

1 reference

15 August 2017

Gregory N Clarke

4

1 reference

15 August 2017

Martin B Keller

7

1 reference

15 August 2017

Neal D Ryan

10

1 reference

15 August 2017

James T McCracken

11

1 reference

15 August 2017

Michael J Strober

12

1 reference

15 August 2017

Satish Iyengar

13

1 reference

15 August 2017

Giovanna Porta

14

1 reference

15 August 2017

David A Brent

15

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

Journal of Clinical Psychopharmacology

15 August 2017

1 reference

15 August 2017

31

1 reference

15 August 2017

1

1 reference

15 August 2017

92-97

1 reference

Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) survey

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

The effect of reporting methods for dosing times on the estimation of pharmacokinetic parameters of escitalopram

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Practice parameter for the assessment and treatment of children and adolescents with depressive disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Time course of response to paroxetine: influence of plasma level

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Imipramine in prepubertal major depressive disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Time course of clinical response to venlafaxine: relevance of plasma level and chirality

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Considerations in Analyzing Single‐Trough Concentrations Using Mixed‐Effects Modeling

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Venlafaxine: the relationship between dose, plasma concentration and clinical response in depressive patients

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Sertraline pharmacokinetics and dynamics in adolescents

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3603695

Plasma levels of citalopram enantiomers and metabolites in elderly patients

5 September 2018

1 reference

12 December 2020

Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory study

1 reference

12 December 2020

Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detection

1 reference

12 December 2020

Treatment with venlafaxine extended release after SSRI nonresponse or intolerance: a randomized comparison of standard- and higher-dosing strategies

1 reference

12 December 2020

10.1097/JCP.0B013E318204B117

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

21192150

1 reference